Dámaso Molero
Vorstandsvorsitzender bei 3P Biopharmaceuticals SL
Aktive Positionen von Dámaso Molero
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
3P Biopharmaceuticals SL
 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Vorstandsvorsitzender | 01.04.2007 | - |
| Präsident | 16.12.2009 | 30.01.2014 |
Karriereverlauf von Dámaso Molero
Ehemalige bekannte Positionen von Dámaso Molero
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - | - |
| Syntex, Inc. | Corporate Officer/Principal | - | - |
| Glaxo, Inc. | Corporate Officer/Principal | - | - |
Ausbildung von Dámaso Molero
| University of Navarra | Masters Business Admin |
Statistik
International
| Spanien | 3 |
| Kanada | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 1 |
| President | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SHIONOGI & CO., LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Health Technology |
| Glaxo, Inc. | |
| Syntex, Inc. | Miscellaneous |
- Börse
- Insiders
- Dámaso Molero
- Erfahrung
